These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Change: embrace it or move over. Kremer JM Curr Opin Rheumatol; 2013 May; 25(3):285-6. PubMed ID: 23492741 [No Abstract] [Full Text] [Related]
6. [Immunosuppressive therapy with cytostatic agents in rheumatology]. Borrachero del Campo J Rev Esp Reum Enferm Osteoartic; 1969 Oct; 13(4):204-14. PubMed ID: 4937879 [No Abstract] [Full Text] [Related]
7. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice. Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800 [TBL] [Abstract][Full Text] [Related]
8. Topical antirheumatic drug therapy: current practice and future trends. Dreiser RL Eur J Rheumatol Inflamm; 1994; 14(4):3-8. PubMed ID: 7601180 [No Abstract] [Full Text] [Related]
9. Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology. Seidel MF Future Med Chem; 2012 Apr; 4(6):705-7. PubMed ID: 22530634 [No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy in rheumatology]. Arsov D; Guceva B Acta Med Iugosl; 1970; 24(3):251-67. PubMed ID: 5205529 [No Abstract] [Full Text] [Related]
12. [New trends in rheumatology. The Danish Society of Rheumatology]. Andersen LS; Gam AN; Hansen A; Kollerup G; Rasmussen C; Rasmussen JM; Schiøttz-Christensen B; Slot O; Thamsborg G Ugeskr Laeger; 2003 Mar; 165(12):1255. PubMed ID: 12701305 [No Abstract] [Full Text] [Related]
13. [Current treatment of collagen diseases. 3. Antirheumatic agents: key points in their application]. Yamada A Nihon Naika Gakkai Zasshi; 1997 Aug; 86(8):1405-8. PubMed ID: 9410945 [No Abstract] [Full Text] [Related]
14. Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis. Villa-Forte A; Hoffman GS Nat Clin Pract Rheumatol; 2008 Jun; 4(6):284-5. PubMed ID: 18446138 [No Abstract] [Full Text] [Related]
15. [Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)]. Díaz-Jouanen E; Abud-Mendoza C; Garza-Elizondo MA; Medrano-Ramírez G; Burgos-Vargas R; Orozco-Alcalá JJ; Pacheco-Tena CF; Pineda C; Pozos-Espíndola JC; Ramos-Niembro F; Robles-San-Román M; Santana-Sahagún JE; Rev Invest Clin; 2009; 61(3):252-66. PubMed ID: 19736814 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 and rheumatology: Reflecting on the first wave and preparing for the second wave. Fardanesh A; Byravan S; Moorthy A; Tahir H Int J Rheum Dis; 2021 Jan; 24(1):7-9. PubMed ID: 33459529 [No Abstract] [Full Text] [Related]
17. [Intra-articular infiltrations in rheumatology: update]. Chevalier-Ruggeri P; Zufferey P Rev Med Suisse; 2016 Jan; 12(500):90-4. PubMed ID: 26946713 [TBL] [Abstract][Full Text] [Related]
18. Clinical trials in pediatric rheumatology: comment on the editorial by Lehman. DeWitt EM; Ardoin SP; Rabinovich CE; Schanberg LE Arthritis Rheum; 2008 Apr; 58(4):1202-3; author reply 1203. PubMed ID: 18383362 [No Abstract] [Full Text] [Related]
19. Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice. Haraoui B J Rheumatol; 2009 Aug; 36(8):1561-2. PubMed ID: 19671804 [No Abstract] [Full Text] [Related]
20. [Continuous quick development of rheumatology]. Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087 [No Abstract] [Full Text] [Related] [Next] [New Search]